Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
Human Antibodies|September 13, 2021
Circulating macrophage inflammatory protein-1β/IL-12p40 ratio predicts sofosbuvir-based treatment outcome in HCV- genotype 4 patientsHeba Shawky, Reem El-Shenawy, Naiera M Helmy
F1000Research|February 7, 2017
Statin (3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor)-based therapy for hepatitis C virus (HCV) infection-related diseases in the era of direct-acting antiviral agentsSara Sobhy Kishta, Sobhy Ahmed Kishta, Reem El-Shenawy
The Egyptian Journal of Immunology|January 15, 2024
Prevalence of viral hepatitis (A, B, C, and E) infection and co-infection among hospitalized children in Cairo, EgyptEnas Mostafa, Reem El-Shenawy, Ashraf Tabll, et al.
Human Antibodies|May 26, 2019
Serum inducible protein-10 chemokine as a biomarker for clearance of HCV with and without treatment in Egyptian patientsAshraf Tabll, Reem El Shenawy, Hazem Elsharkawy, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|April 29, 2022
Polyphenol Content, Antioxidant, Cytotoxic, and Genotoxic Activities of Bombax ceiba Flowers in Liver Cancer Cells Huh7Kawthar A Diab, Reem El-Shenawy, Naiera M Helmy, et al.
Biomarkers in Medicine|April 25, 2023
Overexpression of miRNA 26a and 26b with MMP-9 are valuable diagnostic biomarkers for colorectal cancer patientsSally Farouk, Reem El-Shenawy, Ahmed M Khairy, et al.
Saudi Journal of Biological Sciences|May 10, 2023
Harnessing immunoinformatics for developing a multiple-epitope peptide-based vaccination approach against SARS-CoV-2 spike proteinRehab I Moustafa, Ahmed H I Faraag, Reem El-Shenawy, et al.
The Egyptian Journal of Immunology|July 12, 2024
Immunogenicity study of a Novel DNA-Based HCV vaccine candidateEman A Salem, Ashraf Tabll, Tamer Z Salem, et al.
Human Antibodies|December 31, 2018
Safety and tolerability of mice to repeated subcutaneous injections of a peptide mix as a potential vaccine against HCV infectionReham M Dawood, Ghada M Salum, Tawfeek H Abdelhafez, et al.
Virology Journal|November 16, 2024
Peripheral immune signatures associated with the risk of hepatocarcinogenesis in cirrhotic Egyptian HCV patients before and after treatment with direct-acting antiviralsReem El-Shenawy, Rehab I Moustafa, Naiera M Helmy, et al.
Pageof 4